Acetylon Pharmaceuticals to Present at UBS Global Healthcare Conference
BOSTON, May 20, 2013 (BUSINESS WIRE) – Acetylon Pharmaceuticals Inc., the leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that Walter C. Ogier, President and Chief Executive Officer of Acetylon, will present at the UBS Global Healthcare Conference today, May 20, 2013, at 1:00 p.m. ET in New York [...]
- By diradiocast
- On May, 22, 2013
- Sickle Cell News Post
- No Comments.
Sangamo BioSciences Presents New Data From In Vivo Protein Replacement …
Production of Therapeutically Relevant Levels of Clotting Factor VIII Further Demonstrates Breadth and Leverage of this Novel Approach to Monogenic Diseases Presentations at ASGCT Annual Meeting Highlight Broad Applicability of ZFP Technology RICHMOND, Calif., May 20, 2013 /PRNewswire/ — Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new data demonstrating the successful application of [...]
- By diradiocast
- On May, 20, 2013
- Sickle Cell News Post
- No Comments.
Advocate on Capital Hill for increased Sickle Cell Funding
Here is your opportunity – sign up to join The Sickle Cell Disease Association of American on (SCDAA) June 25 & 26 as they advocate on Capital Hill for increased funding. If you are not able to attend both days (Tuesday andWednesday) but would like to attend just on Wednesday, please contact SCDAA for more details. Please call them at: 410- [...]
Read More- By diradiocast
- On May, 20, 2013
- Advocacy
- No Comments.
Acetylon Pharmaceuticals to Present at UBS Global Healthcare Conference
Blood cancers such as multiple myeloma are characterized by successive genetic mutations resulting in rapid cell proliferation and excess production of intracellular proteins. ACY-1215 selectively inhibits the intracellular enzyme HDAC6, leading to inactivation of the “aggresome” pathway for degradation of damaged proteins. The resultant accumulation of excess waste protein in malignant cells triggers programmed cell [...]
- By diradiocast
- On May, 20, 2013
- Sickle Cell News Post
- No Comments.
Acetylon Pharmaceuticals to Present at UBS Global Healthcare Conference
Blood cancers such as multiple myeloma are characterized by successive genetic mutations resulting in rapid cell proliferation and excess production of intracellular proteins. ACY-1215 selectively inhibits the intracellular enzyme HDAC6, leading to inactivation of the “aggresome” pathway for degradation of damaged proteins. The resultant accumulation of excess waste protein in malignant cells triggers programmed cell [...]
- By diradiocast
- On May, 20, 2013
- Sickle Cell News Post
- No Comments.
Meet the gene
As Indians approach genetic labs to decode their DNA in a bid to predict risk of fatal disease, TOI asks if this is just a case of discovering the obvious? In 2009, 35 members of Dr Nirmala Vaze’s family underwent a genetic test at the Navi Mumbai-based Advanced Centre for Treatment, Research and Education in [...]
- By diradiocast
- On May, 19, 2013
- Sickle Cell News Post
- No Comments.
Meet the gene
As Indians approach genetic labs to decode their DNA in a bid to predict risk of fatal disease, Mirror asks if is this just a case of discovering the obvious? In 2009, 35 members of Dr Nirmala Vaze’s family underwent a genetic test at the Navi Mumbai-based Advanced Centre for Treatment, Research and Education in [...]
- By diradiocast
- On May, 18, 2013
- Sickle Cell News Post
- No Comments.
Financings of the Fortnight Waits For Public Investors To Hop On Bluebird
It’s been another IPO-intensive couple of weeks here at FOTF HQ. We keep looking for other things to write about, but sometimes the fastest shave on deadline is with Occam’s razor. Or something like that. We didn’t exactly ace our philosophy classes in college. You don’t have to be the sharpest tool in the shed [...]
- By diradiocast
- On May, 17, 2013
- Sickle Cell News Post
- No Comments.
Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir …
Unprecedented Immune Reconstitution Drives HIV Viral Reservoir Depletion Encouraging Preliminary Anti-Viral HIV Data during Treatment Interruption in Ongoing SB-728-T Phase 2 Trials RICHMOND, Calif., May 15, 2013 /PRNewswire/ — Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of new clinical data from its program to develop a ZFP Therapeutic(R) for HIV/AIDS. The data, which [...]
- By diradiocast
- On May, 15, 2013
- Sickle Cell News Post
- No Comments.
‘Very few people can do what Angelina has done’
Mumbai doctors say that while genetic testing for cancer is catching on, preventive procedures – such as the double mastectomy Angelina Jolie opted for – are still rare In a poignant article in The New York Times, actor and director Angelina Jolie on Tuesday announced that after finding out that she carried a faulty gene [...]
- By diradiocast
- On May, 15, 2013
- Sickle Cell News Post
- No Comments.





